LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Company News/Garrett Gingerich and Garrett Hurley Join TayCo Brace, Inc.
Company News

Garrett Gingerich and Garrett Hurley Join TayCo Brace, Inc.

August 22, 2023 2 min read Premium comments

Advertisement

Garrett Gingerich and Garrett Hurley Join TayCo Brace, Inc.
(L to R): Garrett Gingerich and Garrett Hurley / Courtesy of TayCo Brace, Inc.
Secondary#garrettgenrich#garretthurley#taycebrace

South Bend, Indiana based TayCo Brace, Inc. has announced that Garrett Gingerich and Garrett Hurley are the two most recent senior executives to join the company—the creator and producer of an innovative ankle brace that has been employed in more than 20,000 patients, at more than 22 NFL teams and over 80 intercollegiate athletic programs.

Garrett Gingerich is TayCo’s new chief marketing officer and brings to the position almost 20 years of experience building brands through strategic marketing. Prior to TayCo Brace, Gingerich served as the group director of strategy at Pathfinders Advertising. While at Pathfinder, Gingerich re-engineered the in-house digital marketing process for Pathfinder and its clients.

Garrett Hurley is TayCo Brace’s new chief technology officer and brings to TayCo a strong background in prosthetic and orthotic development and engineering.  Prior to joining TayCo, Hurley was founder and CEO of an independent consulting firm and an orthotist and prosthetist at companies such as San Francisco-based Roam Robotics. An inventor with over 40 patents, issued and pending.

“We are thrilled to welcome Garrett Gingerich and Garrett Hurley to our executive team,” said Gavin Ferlic, company co-founder and CEO. “Their extensive industry experience and leadership skills will play a crucial role in driving our strategic growth initiatives and solidifying our position in the market. We are confident their contributions will greatly benefit our company and customers.”

Since its founding in 2016, TayCo Brace has partnered with hospitals, medical practices, military organizations, and athletic programs to improve health outcomes and the ankle recovery experience for more than 20,000 patients and counting.

Its innovative ankle brace helps people in every walk of life—from athletes to weekend warriors and industrial professionals to special forces—function at a normal level with the support they need to accommodate their activities and daily living.

With the addition of Gingerich and Hurley, TayCo Brace is poised to expand its reach in physicians’ offices and consumer markets and recently launched its first off-the-shelf product, now available for purchase without a physician’s order.

TayCo Brace is empowering mobility and stability by raising the standard of care for doctors who want to get their patients back to normal faster, with fewer life disruptions, and exceptional outcomes after ankle and hindfoot injuries. TayCo partners with hospitals, medical practices, military organizations, and athletic trainers across the country to help them outperform traditional therapies and increase long-term mobility with an external ankle brace that’s changing the way recovery looks and feels. The TayCo Brace has been used by over 20,000 patients, 80+ NCAA football teams, 22+ NFL teams, and special forces. Founded in 2016 as a product of the University of Notre Dame’s IDEA Center, TayCo Brace has been listed as a Top 10 Innovation in Podiatry, a winner of the “For Such A Time As This – OrthoChallenge,” and received the 1st Source Bank Commercialization Award.

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy